WHO ICTRP trial

Effect of dexamethasone for preventing nausea and vomiting post operatively and…

CTRI/2023/10/058188 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2023/10/058188
Public title Effect of dexamethasone for preventing nausea and vomiting post operatively and its effect on blood sugar levels in patients undergoing ent surgeries
Scientific title Effect of single dose dexamethasone (0.1mg/kg) in preventing Post operative nausea and vomiting and its effect on blood glucose in diabetics and non diabetics in ent surgeries - Nil
Primary sponsor Kempegowda institute of medical sciences and research centre Bangalore
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries India
Interventions Intervention1: dexamathasone 0.1mg/kg: single dose dexamethasone 0.1mg/kg given before starting the surgery intravenously in diabetics and monitoring grbs 2nd hourly from starting of surgery upto 24 hours Control Intervention1…
Registration date Mar 10, 2023
Target size 60
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations